Hyaluronidase (ovine)
- Generic Name
- Hyaluronidase (ovine)
- Brand Names
- Vitrase
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 488712-31-8
- Unique Ingredient Identifier
- 64R4OHP8T0
- Background
Highly purified sheep hyaluronidase for administration by injection into the vitreous of the eye.
- Indication
For increase of absorption and distribution of other injected drugs and for rehydration.
- Associated Conditions
- Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma ( FL), Refractory Follicular Lymphoma, Relapsed Follicular Lymphoma, Non-progressive Follicular Lymphoma, Stable Follicular Lymphoma
- Associated Therapies
- Parenteral rehydration therapy, Improving resorption of radiopaque agents, To increase percutaneous drug absorption therapy
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath